Insider Selling: Rapid Micro Biosystems (NASDAQ:RPID) Major Shareholder Sells $116,875.00 in Stock

Rapid Micro Biosystems, Inc. (NASDAQ:RPID) major shareholder Longitude Capital Partners Ii, sold 27,500 shares of the firm’s stock in a transaction dated Monday, February 2nd. The shares were sold at an average price of $4.25, for a total transaction of $116,875.00. Following the transaction, the insider owned 76,500 shares of the company’s stock, valued at approximately $325,125. This trade represents a 26.44% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Major shareholders that own at least 10% of a company’s shares are required to disclose their transactions with the SEC.

Longitude Capital Partners Ii, also recently made the following trade(s):

• On Friday, January 30th, Longitude Capital Partners Ii, sold 46,000 shares of Rapid Micro Biosystems stock. The stock was sold at an average price of $4.54, for a total value of $208,840.00.
• On Friday, January 23rd, Longitude Capital Partners Ii, sold 7,739 shares of Rapid Micro Biosystems stock. The stock was sold at an average price of $4.06, for a total value of $31,420.34.

Rapid Micro Biosystems Trading Down 5.4%

Shares of RPID opened at $3.68 on Friday. The business’s 50-day moving average price is $3.67 and its 200 day moving average price is $3.40. The company has a current ratio of 4.23, a quick ratio of 2.95 and a debt-to-equity ratio of 0.42. The stock has a market capitalization of $163.10 million, a P/E ratio of -3.64 and a beta of 1.38. Rapid Micro Biosystems, Inc. has a 1-year low of $1.86 and a 1-year high of $4.94.

Rapid Micro Biosystems (NASDAQ:RPID) last released its earnings results on Friday, November 7th. The company reported ($0.26) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.26). Rapid Micro Biosystems had a negative return on equity of 73.90% and a negative net margin of 145.11%.The company had revenue of $7.84 million during the quarter, compared to analyst estimates of $7.60 million. Analysts expect that Rapid Micro Biosystems, Inc. will post -1.1 earnings per share for the current year.

Analysts Set New Price Targets

A number of research firms recently issued reports on RPID. Weiss Ratings reissued a “sell (d-)” rating on shares of Rapid Micro Biosystems in a research report on Thursday, January 22nd. Wall Street Zen downgraded Rapid Micro Biosystems from a “hold” rating to a “sell” rating in a research note on Saturday, January 17th. One investment analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $8.00.

Institutional Investors Weigh In On Rapid Micro Biosystems

Hedge funds have recently bought and sold shares of the company. Hudson Bay Capital Management LP acquired a new stake in shares of Rapid Micro Biosystems in the third quarter worth $38,000. Susquehanna International Group LLP boosted its holdings in Rapid Micro Biosystems by 12.6% in the 3rd quarter. Susquehanna International Group LLP now owns 58,387 shares of the company’s stock valued at $195,000 after purchasing an additional 6,528 shares during the period. Dimensional Fund Advisors LP grew its position in Rapid Micro Biosystems by 37.8% in the 3rd quarter. Dimensional Fund Advisors LP now owns 55,642 shares of the company’s stock worth $186,000 after purchasing an additional 15,255 shares during the last quarter. Evernest Financial Advisors LLC increased its holdings in shares of Rapid Micro Biosystems by 355.1% during the 3rd quarter. Evernest Financial Advisors LLC now owns 200,234 shares of the company’s stock worth $669,000 after purchasing an additional 156,234 shares during the period. Finally, Vanguard Group Inc. raised its position in shares of Rapid Micro Biosystems by 6.7% during the third quarter. Vanguard Group Inc. now owns 965,018 shares of the company’s stock valued at $3,223,000 after buying an additional 60,655 shares during the last quarter. 52.60% of the stock is currently owned by institutional investors.

About Rapid Micro Biosystems

Rapid Micro Biosystems (NASDAQ: RPID) develops and commercializes automated microbial detection and contamination control solutions for the life sciences industry. Its flagship offering, the Growth Direct® System, leverages digital imaging and proprietary growth indicator plates to identify and count microorganisms more rapidly than traditional culture-based methods. The company’s technology platform is designed to streamline quality control workflows in pharmaceutical, biotechnology and vaccine manufacturing settings, helping clients reduce release times and improve operational efficiency.

In addition to the Growth Direct® System, Rapid Micro Biosystems offers an integrated suite of software and consumables that support automated data capture, analysis and reporting.